1.95
前日終値:
$2.07
開ける:
$2.07
24時間の取引高:
994.81K
Relative Volume:
1.05
時価総額:
$25.86M
収益:
-
当期純損益:
$-7.51M
株価収益率:
-1.4773
EPS:
-1.32
ネットキャッシュフロー:
$-8.02M
1週間 パフォーマンス:
+11.75%
1か月 パフォーマンス:
+50.00%
6か月 パフォーマンス:
+82.24%
1年 パフォーマンス:
+126.74%
Hoth Therapeutics Inc Stock (HOTH) Company Profile
名前
Hoth Therapeutics Inc
セクター
電話
(646)756-2997
住所
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
HOTH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
HOTH
Hoth Therapeutics Inc
|
1.95 | 27.45M | 0 | -7.51M | -8.02M | -1.32 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2019-10-15 | 開始されました | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc (HOTH) 最新ニュース
Hoth expands HT-001 development with patents for cancer therapy side effects - Investing.com India
Hoth Therapeutics Expands Patent Portfolio for HT-001 to Target Wider Range of Skin Toxicities - MarketScreener
Novel Drug Could Help Cancer Patients Stay on Life-Saving Treatments: Hoth's HT-001 Targets Multiple Skin Effects - Stock Titan
Hoth Therapeutics, Inc. (HOTH) Files EMA Application for Global Expansion of HT-001 Skin Therapy - Yahoo Finance
Chart Watch: Can Hoth Therapeutics Inc stock double in the next year2025 Trade Ideas & Community Verified Watchlist Alerts - خودرو بانک
Bull Run: Will Hoth Therapeutics Inc benefit from rising consumer demandMarket Performance Report & Risk Controlled Stock Pick Alerts - خودرو بانک
New Highs: Whats the MACD signal for Hoth Therapeutics IncWeekly Trend Recap & Proven Capital Preservation Tips - خودرو بانک
Risks Report: Whats the outlook for Hoth Therapeutics Incs sectorWeekly Trading Summary & Daily Price Action Insights - خودرو بانک
Market Review: Is NGVT a momentum stockMarket Weekly Review & Risk Controlled Swing Alerts - khodrobank.com
Is Hoth Therapeutics Inc benefiting from innovation trendsEarnings Recap Report & Real-Time Volume Surge Alerts - خودرو بانک
Market Outlook: Will Hoth Therapeutics Inc. announce a stock splitQuarterly Profit Summary & Advanced Swing Trade Entry Alerts - خودرو بانک
Aug Shorts: How correlated is Hoth Therapeutics Inc to the S P500July 2025 Big Picture & Expert Verified Movement Alerts - خودرو بانک
Risk Analysis: What are the future prospects of NEEPRTTrade Ideas & Real-Time Sentiment Analysis - خودرو بانک
Take Profit: Will Hoth Therapeutics Inc benefit from rising consumer demand2025 Risk Factors & High Conviction Buy Zone Picks - خودرو بانک
Risk Hedge: Is Monster Beverage Corporation a defensive stockProduct Launch & Daily Risk Controlled Trade Plans - خودرو بانک
Hoth Therapeutics issues update- HT-001, HT-KIT, VA Obesity Program drive strongest position in company history - MarketScreener
Hoth Therapeutics Issues Shareholder Update: HT-001, HT-KIT, Expanded Treasury Reserve Strategy, and VA Obesity Program Drive Strongest Position in Company History - PR Newswire
Support Test: What is the dividend yield of Hoth Therapeutics Inc2025 Biggest Moves & Entry Point Confirmation Signals - خودرو بانک
$1M Crypto Treasury Plan: Hoth Therapeutics Expands Global Trial Network While Adding Bitcoin Strategy - Stock Titan
Risk Off: What is Hoth Therapeutics Inc. s debt to equity ratioJuly 2025 Price Swings & Advanced Swing Trade Entry Plans - خودرو بانک
What MACD and RSI say about Hoth Therapeutics Inc.July 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Will Hoth Therapeutics Inc. announce a stock splitMarket Trend Report & Weekly Consistent Profit Watchlists - خودرو بانک
Stock Report: What is the dividend yield of Hoth Therapeutics IncCPI Data & Trade Opportunity Analysis Reports - خودرو بانک
Hoth Therapeutics climbs on $1 million crypto reserve plan - TradingView
Hoth Therapeutics climbs on $1 mln crypto reserve plan - TradingView
Hoth Therapeutics approved expansion of treasury reserve strategy to include Ethereum and Solana - MarketScreener
Hoth Therapeutics Announces Positive Findings on GDNF's Potential as a Game-Changer in Obesity Treatment and Reduced Fatty Liver Disease - 富途牛牛
Hoth Therapeutics submits European application for skin toxicity drug - Investing.com
Hoth Therapeutics submits European application for skin toxicity drug By Investing.com - Investing.com Nigeria
Hoth Therapeutics reaches EMA milestone for HT-001 phase II trial targeting EGFRi-linked skin toxicities - MarketScreener
Hoth Therapeutics Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities - WV News
3 Under-the-Radar Biotechs Under $5 That Could Soar 200% - MarketBeat
Chart Analysts Warn of Resistance Near Hoth Therapeutics Inc. PriceJuly 2025 Market Mood & Capital Efficiency Focused Ideas - beatles.ru
How does Hoth Therapeutics Inc. correlate with NasdaqWeekly Trend Summary & High Win Rate Trade Tips - classian.co.kr
Earnings visualization tools for Hoth Therapeutics Inc.2025 Stock Rankings & Expert Approved Momentum Ideas - Newser
Can Hoth Therapeutics Inc. stock double in the next year2025 Earnings Impact & Stepwise Trade Signal Guides - خودرو بانک
Published on: 2025-09-06 01:25:14 - خودرو بانک
Hoth Therapeutics shares fall 2.24% premarket after adopting Lantern Pharma's AI-driven drug development tool. - AInvest
Is Hoth Therapeutics Inc. building a consolidation basePortfolio Profit Report & Weekly Hot Stock Watchlists - Newser
Is Hoth Therapeutics Inc. trending in predictive chart modelsPortfolio Update Summary & Reliable Intraday Trade Plans - Newser
Hoth Therapeutics adopts AI platform to advance drug development By Investing.com - Investing.com Canada
Is Hoth Therapeutics Inc. a momentum stockRate Cut & Risk Managed Investment Entry Signals - خودرو بانک
Hoth Therapeutics adopts AI platform to advance drug development - Investing.com India
Hoth Therapeutics shares fall 1.49% after-hours after adopting Lantern Pharma's AI-driven drug development tool. - AInvest
What indicators show strength in Hoth Therapeutics Inc.Dividend Hike & Real-Time Stock Movement Alerts - Newser
Lantern Pharma shares fall 1.52% intraday after FDA meeting and Hoth Therapeutics partnership. - AInvest
Using AI based signals to follow Hoth Therapeutics Inc.2025 Momentum Check & Free Community Consensus Stock Picks - Newser
AI-Driven Drug Development: Hoth Therapeutics and Lantern Pharma’s Strategic Partnership to Revolutionize CNS Therapies - AInvest
Lantern Pharma's PredictBBB.ai Platform to Drive Next-Gen Drug Development with Hoth Therapeutics Partnership - AInvest
Hoth Therapeutics Taps Lantern Pharma's PredictBBB.ai Platform -- Breakthrough AI With 94% Accuracy Driving Next-Gen Drug Development - PR Newswire
Is Hoth Therapeutics Inc. benefiting from innovation trendsWeekly Profit Analysis & Smart Investment Allocation Tips - خودرو بانک
Hoth Therapeutics Inc (HOTH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):